Zhi, W. Iris
Baser, Raymond E.
Talukder, Dristi
Mei, Ying Zi
Harte, Steven E.
Bao, Ting http://orcid.org/0000-0003-4437-2597
Clinical trials referenced in this document:
Documents that mention this clinical trial
Chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer survivors: a comparison of patient-reported outcomes and quantitative sensory testing
https://doi.org/10.1007/s10549-019-05416-4
Mechanistic and thermal characterization of acupuncture for chemotherapy-induced peripheral neuropathy as measured by quantitative sensory testing
https://doi.org/10.1007/s10549-022-06846-3
Funding for this research was provided by:
Division of Cancer Prevention, National Cancer Institute (P30 CA008748, R37CA248563, R01CA240417, R01CA251470)
Translational and Integrative Medicine Research Fund
Frueauff Foundation
Gateway for Cancer Research (G-22-1200)
Article History
Received: 19 August 2022
Accepted: 9 December 2022
First Online: 17 December 2022
Declarations
:
: We certify that there are no affiliations with or involvement in any organization or entity with any financial interest or other equity interests or non-financial interests that influenced the design, outcome, and submission of this study.
: This study was approved by Memorial Sloan Kettering’s Institutional Review Board and the clinical trial was registered at ClinicalTrials.gov (NCT03183037). All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.